=== PAGE 3 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Here is the text content from the PDF page, preserving the original layout and structure:

**Image Description:**
At the top left of the page is the company logo, which consists of a stylized blue infinity loop symbol to the left of the words "NASCENT BIOTECH, INC.".
To the right of the main headline, there is a complex, multi-colored (green, light blue, dark blue, purple) 3D molecular structure, likely representing an antibody molecule, consistent with the surrounding text about antibodies and biotech.

**Extracted Text:**

**NASCENT**
**BIOTECH, INC.**

Products Investors News About Contact

**Pritumumab**
**has cured a rare form of**
**brain cancer**

Delivering human antibodies for the treatment of cancer

---

**Pritumumab**

Learn more about Nascent Biotech's primary drug product,
Pritumumab.

**NBIO Stock Information**

NBIO: [%]

**Investor Presentation**

Download Investor Presentation

**Email Updates**
[ ] Subscribe Now

---

**Latest News**

JUNE 3, 2019
Nascent CEO Sean Carrick On RedChip Money Report

MARCH 10, 2019
Human Antibodies: Antibody drug conjugates: Progress, pitfalls, and
promises

DECEMBER 11, 2018
Nascent Biotech Receives Clearance from FDA to Begin Phase I Human
Trials in Brain Cancer

JULY 27, 2018
Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic
antibodies toward the paratope of malignant associated autologous anti-
vimentin antibody, CLN-IgG (Pritumumab)

APRIL 4, 2018
Nascent Biotech to Sponsor Human Antibodies & Hybridomas
Conference

---

Copyright Nascent Biotech. All rights reserved.
